Delhi High Court reserves verdict in challenge to FDC drug banJune 2 2016
Justice RS Endlaw of the Delhi High Court has reserved judgment on the petitions filed by pharma companies challenging the Health Ministry’s ban on 344 FDC (Fixed Dose Combination) drugs.
Justice Endlaw who has been hearing final arguments in the case for two months now, reserved his orders today on a batch of nearly 300-odd petitions filed by different pharma companies.
With a premium account you get:
Already a subscriber ?